Jury finds Lilly breaches implied covenant in rezpegaldesleukin license, awards Nektar $90 million plus interest
NKTR•A U.S. jury found Lilly breached the implied covenant of good faith in its rezpegaldesleukin license agreement with Nektar and awarded $90 million, with interest to be determined by the court.
1. Jury verdict
The verdict followed a jury trial that began Sept. 8, 2026, in federal court in Northern California. Post-trial motions remain pending, and any final judgment could face appeal.
